JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Vital Signs - Managing Type 2 Diabetes: Risk vs. Reward

Vital Signs - Managing Type 2 Diabetes: Risk vs. Reward

RELEASE DATE
13-Aug-2007

REGION
North America

Research Code: 9561-00-3E-00-00

SKU: HC00494-NA-MR_03966

$1,500.00

Special Price $1,125.00 save 25 %

In stock

SKU

HC00494-NA-MR_03966

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Description
Table of Contents
Request Sample

Description

This issue of Vital Signs, released on August 13, 2007, provides a strategic overview of recent adverse risk issues impacting Avandia. Additionally, a company spotlight is provided for DiaKine Therapeutics, a developer of innovative therapies for diabetes and related complications. Reimbursement and regulatory news from the FDA is also provided for the week of July 30 - August 3, 2007.

Table of Contents

Vital Signs: 13 August 2007

This week's issue:

Popular Topics

solar energy market

dietary supplements market

biometric authentication market

silicone market

3d printer market share

solar panel market

heavy truck market

residential solar market

heavy commercial vehicles market

diabetes market

This issue of Vital Signs, released on August 13, 2007, provides a strategic overview of recent adverse risk issues impacting Avandia. Additionally, a company spotlight is provided for DiaKine Therapeutics, a developer of innovative therapies for diabetes and related complications. Reimbursement and regulatory news from the FDA is also provided for the week of July 30 - August 3, 2007.

More Information

More Information
No Index	Yes
Podcast	No
Industries	Healthcare
WIP Number	9561-00-3E-00-00
Is Prebook	No